The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?

Gynecologic Oncology

Volumn 142, Issue 2, 2016, Pages 243-247

  Ataseven, Beyhan ^a   Harter, Philipp ^a   Grimm, Christoph ^a,b   Heitz, Florian ^a   Heikaus, Sebastian ^a   Traut, Alexander ^a   Kahl, Annett ^a   Kurzeder, Christian ^a   Prader, Sonia ^a   du Bois, Andreas ^a  

^a KLINIKEN ESSEN MITTE   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

New FIGO classification; Overall survival; Stage IV epithelial ovarian cancer

Indexed keywords

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; DISTANT METASTASIS; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PANCREAS METASTASIS; PLEURA METASTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPLEEN METASTASIS; SURVIVAL RATE; SURVIVAL TIME; CLASSIFICATION; FACTUAL DATABASE; KAPLAN MEIER METHOD; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; DATABASES, FACTUAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84969595272     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.05.021     Document Type: Article

References (9)

1. [1] Gospodarowicz, M.K., Miller, D., Groome, P.A., Greene, F.L., Logan, P.A., Sobin, L.H., The process for continuous improvement of the TNM classification. Cancer 100 (2004), 1–5.
2. [2] Odicino, F., Pecorelli, S., Zigliani, L., Creasman, W.T., History of the FIGO cancer staging system. Int. J. Gynaecol. Obstet. 101 (2008), 205–210.
3. [3] Prat, J., Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int. J. Gynaecol. Obstet. 124 (2014), 1–5.
4. [4] du Bois, A., Quinn, M., Thigpen, T., Vermorken, J., Avall-Lundqvist, E., Bookman, M., et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann. Oncol. 16:Suppl. 8 (2005), viii7–viii12.
5. [5] Stuart, G.C., Kitchener, H., Bacon, M., duBois, A., Friedlander, M., Ledermann, J., et al. Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int. J. Gynecol. Cancer 21 (2010), 750–755.
6. [6] Eitan, R., Levine, D.A., Abu-Rustum, N., Sonoda, Y., Huh, J.N., Franklin, C.C., et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer 103 (2005), 1397–1401.
7. [7] Paik, E.S., Lee, Y.Y., Lee, E.J., Choi, C.H., Kim, T.J., Lee, J.W., et al. Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification. Obstet. Gynecol. Sci. 58 (2015), 124–134.
8. [8] Ataseven, B., Grimm, C., Harter, P., Heitz, F., Traut, A., Prader, S., et al. Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV. Gynecol. Oncol. 140:2 (2016), 215–220.
9. [9] du Bois, A., Reuss, A., Pujade-Lauraine, E., Harter, P., Ray-Coquard, I., Pfisterer, J., Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux pour les Etudes des cancers de l'Ovaire (GINECO). Cancer 115 (2009), 1234–1244.